Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti‐phosphatidyl‐serine/prothrombin antibodies to lupus anticoagulant activity. (17th March 2020)
- Record Type:
- Journal Article
- Title:
- Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti‐phosphatidyl‐serine/prothrombin antibodies to lupus anticoagulant activity. (17th March 2020)
- Main Title:
- Tetra positive thrombotic antiphospholipid syndrome: Major contribution of anti‐phosphatidyl‐serine/prothrombin antibodies to lupus anticoagulant activity
- Authors:
- Cattini, Maria Grazia
Bison, Elisa
Pontara, Elena
Cheng, Chunyan
Denas, Gentian
Pengo, Vittorio - Abstract:
- Abstract: Background: The concurrent presence of lupus anticoagulant, anticardiolipin, and anti β2‐glycoprotein I antibodies (triple positive profile) identifies patients at high risk of thromboembolic events. These patients are also positive for anti‐phosphatidyl‐serine/prothrombin antibodies (tetra‐positive profile). Objective: Understand which antibody among anti‐β2‐glycoprotein I and anti‐phosphatidyl‐serine/prothrombin is responsible for lupus anticoagulant activity. Patients/Methods: Affinity purified anti‐β2‐glycoprotein I antibodies from plasma of 14 tetra‐positive patients spiked into normal pooled plasma were tested. Results and Conclusions: Anti‐β2‐glycoprotein I antibodies did not prolong the diluted Russell viper venom time and silica clotting time (median ratio 0.98, interquartile ratio [IQR] 0.9‐1.06; and 1.0, IQR 0.91‐1.03, respectively). Anticoagulant activity remained in the flow‐through that was deprived of anti‐β2 glycoprotein I antibodies (median ratio 1.88, IQR 1.58‐2.77; and 1.75, IQR 1.17‐2.9, respectively). This material was loaded on size‐exclusion chromatography Sephacryl S‐300 column and showed that anticoagulant activity and anti‐phosphatidyl‐serine/prothrombin antibodies coeluted in the same fractions. Besides, the flow through was poured into a prothrombin affinity column. Protein yield in three patients ranged from 54 to 91 μg/mL and showed strong positivity in phosphatidyl‐serine/prothrombin ELISA. The affinity purified material prolonged theAbstract: Background: The concurrent presence of lupus anticoagulant, anticardiolipin, and anti β2‐glycoprotein I antibodies (triple positive profile) identifies patients at high risk of thromboembolic events. These patients are also positive for anti‐phosphatidyl‐serine/prothrombin antibodies (tetra‐positive profile). Objective: Understand which antibody among anti‐β2‐glycoprotein I and anti‐phosphatidyl‐serine/prothrombin is responsible for lupus anticoagulant activity. Patients/Methods: Affinity purified anti‐β2‐glycoprotein I antibodies from plasma of 14 tetra‐positive patients spiked into normal pooled plasma were tested. Results and Conclusions: Anti‐β2‐glycoprotein I antibodies did not prolong the diluted Russell viper venom time and silica clotting time (median ratio 0.98, interquartile ratio [IQR] 0.9‐1.06; and 1.0, IQR 0.91‐1.03, respectively). Anticoagulant activity remained in the flow‐through that was deprived of anti‐β2 glycoprotein I antibodies (median ratio 1.88, IQR 1.58‐2.77; and 1.75, IQR 1.17‐2.9, respectively). This material was loaded on size‐exclusion chromatography Sephacryl S‐300 column and showed that anticoagulant activity and anti‐phosphatidyl‐serine/prothrombin antibodies coeluted in the same fractions. Besides, the flow through was poured into a prothrombin affinity column. Protein yield in three patients ranged from 54 to 91 μg/mL and showed strong positivity in phosphatidyl‐serine/prothrombin ELISA. The affinity purified material prolonged the coagulation time of normal pooled plasma: the diluted Russell viper venom ratio in the three patients was 2.09, 1.21, and 1.35; that of silica clotting time was 2.05, 1.5, and 2.13. In conclusion, under the assay conditions used, anticoagulant activity in tetra‐positive antiphospholipid syndrome patients may largely be attributable to anti‐phosphatidyl‐serine/prothrombin antibodies. … (more)
- Is Part Of:
- Journal of thrombosis and haemostasis. Volume 18:Number 5(2020)
- Journal:
- Journal of thrombosis and haemostasis
- Issue:
- Volume 18:Number 5(2020)
- Issue Display:
- Volume 18, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 18
- Issue:
- 5
- Issue Sort Value:
- 2020-0018-0005-0000
- Page Start:
- 1124
- Page End:
- 1132
- Publication Date:
- 2020-03-17
- Subjects:
- antibodies -- β2‐glycoprotein I -- lupus anticoagulant -- prothrombin -- thrombosis
Thrombosis -- Periodicals
Hemostasis -- Periodicals
Blood coagulation disorders -- Periodicals
616.1 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1538-7836 ↗
http://www.blackwellpublishing.com/journals/jth ↗
https://www.sciencedirect.com/journal/journal-of-thrombosis-and-haemostasis ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jth.14765 ↗
- Languages:
- English
- ISSNs:
- 1538-7933
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5069.345000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 13178.xml